Biogen Earnings Beat Expectations, but All Eyes Are on Alzheimer ’s Drug

The company said it was dropping a number of drug-development initiatives, including two stroke drugs.

Source: Reuters: Health - April 25, 2023 Category: Consumer Health News Source Type: news